Substance / Medication

Chloroxine

Overview

Active Ingredient
chloroxine
RxNorm CUI
20875

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Diagnostic Accuracy of Trichoscopy in Inflammatory Scalp Diseases: A Systematic Review.
Golińska Joanna, Sar-Pomian Marta, Rudnicka Lidia · Dermatology · 2022
PMID: 34265772Meta-Analysis
Approach to treatment of refractory dissecting cellulitis of the scalp: a systematic review.
Thomas Jamael, Aguh Crystal · J Dermatolog Treat · 2021
PMID: 31348693Meta-Analysis
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review.
Camela Elisa, Ocampo-Garza Sonia Sofía, Cinelli Eleonora et al. · Dermatol Ther · 2021
PMID: 33559275Meta-Analysis
Zn(II) enhances the antimicrobial effect of chloroxine and structural analogues against drug-resistant ESKAPE pathogens in vitro.
Huang Xiaoyong, Li Qianqian, Yun Shaobo et al. · Biochem Pharmacol · 2024
PMID: 39134284Other
Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway.
Lin Miaomiao, Xiao Yanyi, Dai Yile et al. · Clin Transl Oncol · 2024
PMID: 37848695Preclinical
Nanocrystalline chloroxine possesses broad-spectrum antimicrobial activities and excellent skin tolerability in mice.
Trousil Jiří, Matějková Jana, Dai You-Shan et al. · Nanomedicine (Lond) · 2022
PMID: 35012369Preclinical
Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer.
Silva Vera L, Saxena Jayeta, Nicolini Francesco et al. · Cell Death Dis · 2021
PMID: 33854036PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Chloroxine (substance)
SNOMED CT
126148000
UMLS CUI
C0055461
RxNorm CUI
20875

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.